Rebiotix

About:

Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.

Website: http://rebiotix.com

Twitter/X: Rebiotix

Top Investors: Sofia Fund

Description:

Rebiotix is a development-stage biotechnology company revolutionizing the treatment of challenging GI diseases by harnessing the power of the human microbiome.

Total Funding Amount:

$36.3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Rockville, Minnesota, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)rebiotix.com

Founders:

Erwin Kelen, Lee Jones

Number of Employees:

11-50

Last Funding Date:

2017-09-05

IPO Status:

Private

Industries: